オプションチェーンは、InMed Pharmaceuticalsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、InMed Pharmaceuticalsの市場センチメントを評価します。.

InMed Pharmaceuticals (NASDAQ:INM) 株価情報, オプションチェーン

InMed Pharmaceuticals

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

InMed Pharmaceuticals Inc. - Common Shares

InMed Pharmaceuticals Inc

INmune Bio Inc

InMode Ltd

Inca Minerals Ltd

iShares Intermediate Muni Income Active ETF

Blackboxstocks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBX#NASDAQ">BLBX</a>) shares are moving higher on Wednesday after the company announced it secured financing as it anticipates <a href="https://www.benzinga.com/pressreleases/25/01/g43125093/blackboxstocks-inc-secures-financing-of-up-to-2-000-000-in-anticipation-of-potential-merger">a potential merger</a>.
What To Know: Blackboxstocks entered into a securities purchase agreement under which the purchaser agreed to buy $250,000 worth of senior debentures, as well as amended and restated senior secured convertible debentures with an aggregate principal amount of $2 million, upon certain closing conditions.
Blackboxstocks entered into the agreement on Jan. 17 and is set to receive an initial $250,000. The additional financing is tied to a potential merger deal.
&#8220;We are excited to have completed this transaction as we work towards securing a merger transaction that will create significant stockholder value. This financing will help provide the interim capital we need for our operations as well as anticipated transaction expenses in the near future,&#8221; said Gust Kepler, CEO of Blackboxstocks.
Blackboxstocks shares are moving on above-average volume of more than 197 million shares on Wednesday. The company&#8217;s average session volume over the past 100 days is around 70,000, per data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Blackboxstocks is considered a low-float stock with just 2.58 million shares available for public trading, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. The company also had a market cap of less than $6 million as of Wednesday's close. Low-float, micro-cap stocks can be extremely volatile, which may help explain some of Wednesday's surge.
See Also: <a href="https://www.benzinga.com/25/01/43138517/chipmakers-rally-on-ai-stargate-bet-netflix-soar-bitcoin-falters-amid-trumps-crypto-silence-whats-driving-markets-wednesday">Chipmakers Rally On AI Stargate Bet, Netflix Soars, Bitcoin Falters As Trump Keeps Quiet On Crypto: What&#8217;s Driving Markets Wednesday?</a>
BLBX Price Action: At the time of publication, Blackboxstocks shares were up 237% at $5.66, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: 5846648 from Pixabay.

News

Movers

BLBX

What's Going On With Blackboxstocks Shares Wednesday?

WIIM

Halliburton shares are trading lower following mixed Q4 results and guided for a North America revenue decline.

California Democrat and political commentator Van Jones characterized the act of some people buying Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) as a form of &#8220;prayer,&#8221; reflecting a hope for a better financial outcome amid economic uncertainty and frustration with governmental financial policies.
&#8220;A lot of people are buying crypto as a prayer, as a prayer for a better tomorrow, as a hope that somehow something will go good for them,&#8221; he said on Sunday.
Jones argued that the regulatory approach by the Biden administration has inadvertently <a href="https://www.benzinga.com/news/legal/24/11/41996491/18-republican-states-sue-bidens-sec-over-harsh-crypto-crackdown">stifled innovation</a> in the crypto space.
He criticized the government&#8217;s crackdown on more useful cryptocurrencies, saying, &#8220;the more useful the coin is, the more they got attacked. 
The more useless the coin is, the less they got attacked.&#8221; 
This, according to Jones, led to the current market being dominated by meme coins, due to the lack of development and innovation stifled by regulation. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43136512/bitcoin-is-no-threat-to-the-us-dollar-goldman-sachs-ceo-says">Bitcoin Is No &#8216;Threat&#8217; To The US Dollar, Goldman Sachs CEO Says</a>
He noted that instead of protecting individuals, this overregulation has led to a negative market dynamic.
Adding to the commentary, Ashley Etienne, former Communications Director for former Vice President Kamala Harris, weighed in, labeling President Donald Trump a &#8220;grifter.&#8221;
She referenced reports alleging Trump&#8217;s family made millions from foreign governments during his presidency, and warned against Trump&#8217;s potential to profit from the crypto industry and how that's an "issue of conflicts". 
Etienne emphasized that, &#8220;there was a reason why he was called the grifter in chief in his first term." 
She went on to add &#8220;the consensus was that Donald Trump can be bought, that he can be bought in influence simply by dangling some money over his head.&#8221; 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43133561/bitcoin-could-drop-up-to-20-as-trump-hope-fades-standard-chartered-warns">Bitcoin Could Drop Up To 20% As Trump &#8216;Hope&#8217; Fades, Standard Chartered Warns</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

People Buy Bitcoin As 'Prayer For A Better Tomorrow, CNN Pundit Van Jones Says As Former Harris Aide Slams Trump As 'Grifter In Chief'

CME Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CME#NYSE">CME</a>) short percent of float has fallen 9.09% since its last report. The company recently reported that it has 4.32 million shares sold short, which is 1.2% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.5 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>CME Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737575121_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for CME Gr has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing CME Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, CME Gr's peer group average for short interest as a percentage of float is 3.08%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

(CME) - Analyzing CME Gr's Short Interest

GlucoTrack's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NYSE">GCTK</a>) short percent of float has risen 42.38% since its last report. The company recently reported that it has 560 thousand shares sold short, which is 4.67% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>GlucoTrack Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737575116_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for GlucoTrack has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing GlucoTrack's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, GlucoTrack's peer group average for short interest as a percentage of float is 6.31%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

GCTK

How Is The Market Feeling About GlucoTrack?

Cerence's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRNC#NYSE">CRNC</a>) short percent of float has fallen 30.7% since its last report. The company recently reported that it has 7.09 million shares sold short, which is 16.52% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.73 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Cerence Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737575111_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Cerence has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Cerence's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Cerence's peer group average for short interest as a percentage of float is 6.95%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CRNC

Looking Into Cerence's Recent Short Interest

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 250 points on Wednesday.
The Dow traded up 0.27% to 44,146.86 while the NASDAQ rose 1.29% to 20,010.85. The S&amp;P 500 also rose, gaining, 0.70% to 6,091.74.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/01/43123084/top-3-health-care-stocks-that-could-blast-off-this-quarter">Top 3 Health Care Stocks That Could Blast Off This Quarter</a>
Leading and Lagging Sectors Information technology shares surged by 2.5% on Wednesday.
In trading on Wednesday, utilities shares fell by 1.5%.
Top Headline
Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion.
Adjusted diluted earnings per share were $1.34, in line with the analyst estimates and management consensus of $1.31-$1.37, up from $1.19 a year ago.
Abbott projects full-year 2025 adjusted EPS of $5.05-$5.25 versus a consensus of $5.16, with organic sales growth of 7.5%- 8.5% and an adjusted operating margin of 23.5%- 24.0%. Abbott Laboratories expects first quarter 2025 adjusted EPS of $1.05-$1.09 versus consensus of $1.11.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Blackboxstocks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBX#NASDAQ">BLBX</a>) shares shot up 101% to $3.39 after the company announced a $250K securities purchase agreement and is anticipating a potential merger.</li>
<li>Shares of Absci Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>)got a boost, surging 26% to $4.0450 after Needham initiated coverage with a Buy rating and a $9 price target.</li>
<li>ImmunoPrecise Antibodies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPA#NASDAQ">IPA</a>) shares were also up, gaining 30% to $0.6396 after the company announced it developed a new class of GLP-1 therapies using its LENS platform.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Agilysys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) shares dropped 21% to $100.00 after the company reported worse-than-expected third-quarter sales results and issued FY25 revenue guidance below estimates.</li>
<li>Shares of Hepion Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPA#NASDAQ">HEPA</a>) were down 61% to $0.1265 after the company announced a $9 million public offering.</li>
<li>Lisata Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSTA#NASDAQ">LSTA</a>) was down, falling 30% to $2.72 after the company announced preliminary cohort data from its Phase 2 Ascend trial.</li>
</ul>
Commodities In commodity news, oil traded down 0.4% to $75.55 while gold traded up 0.4% at $2,770.40.
Silver traded down 0.5% to $31.33 on Wednesday, while copper fell 1% to $4.2985.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 surged 0.39%, Germany's DAX 40 rose 1.01% and France's CAC 40 gained 0.86%. Spain's IBEX 35 Index fell 0.37%, while London's FTSE 100 fell 0.04%.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 gaining 1.58%, China's Shanghai Composite Index falling 0.89%, Hong Kong's Hang Seng Index falling 1.63% and India's BSE Sensex gaining 0.75%.
Economics
U.S. mortgage applications rose 0.1% from the previous week in the week ending Jan. 17.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/43125507/apple-to-183-here-are-10-top-analyst-forecasts-for-wednesday">Apple To $183? Here Are 10 Top Analyst Forecasts For Wednesday</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

ABSI

AGYS

HEPA

LSTA

Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales

Goldman Sachs analyst Lizzie Dove initiated coverage on Viking Holdings Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIK#NYSE">VIK</a>) with a Neutral rating<a href="https://www.benzinga.com/quote/VIK/analyst-ratings" target="_blank" rel="noreferrer noopener"> and price forecast of $49.</a>
The analyst highlights that Viking Holdings&#8217; business model has strong appeal due to its high exposure to a growing demographic booking ahead at higher prices and its industry-leading category expansion, which boosts revenue growth.
However, due to the stock rising 73% since its IPO in May 2024 and a valuation premium compared to Royal Caribbean Cruises Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>), the analyst is looking for a better entry point.
The analyst also notes that Viking Holdings high booking visibility (70% booked for 2025) and its desire to maintain a cash cushion suggest less potential for near-term estimate revisions and share repurchases.
Also Read: <a target="_blank" href="https://www.benzinga.com/etfs/sector-etfs/25/01/43135764/trumps-500-billion-stargate-ai-plan-puts-3-etfs-in-focus" rel="noreferrer noopener">Trump&#8217;s $500 Billion Stargate AI Plan Puts 3 ETFs In Focus</a>
Dove points out that Viking Holdings&#8217; core demographic mainly consists of affluent US travelers aged 55+, a fast-growing group with the highest wealth, representing about 30% of the population <a href="https://www.benzinga.com//node/43065113">but over 70% of the wealth.</a>
However, the analyst notes that the company&#8217;s customer base is less new-to-cruise compared to its peers, which has been a major growth driver for the cruise industry over the past two years.
The analyst highlights that Royal Caribbean and Carnival Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) have experienced double-digit growth in new-to-cruise passengers, with around half of their guests being millennials or younger.
While Viking Holdings has an appealing demographic and a strong pipeline of potential cruisers, Dove sees less opportunity for Viking Holdings to benefit from the new-to-cruise growth that has supported the broader industry.
Price Action: VIK shares are trading lower by 1.30% to $47.86 at last check Wednesday.
See Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/01/43128141/tech-stocks-rise-after-trump-announces-ai-infrastructure-investment" target="_blank" rel="noreferrer noopener">Tech Stocks Rise After Trump Announces AI Infrastructure Investment</a></li>
</ul>
Photo via Shutterstock.

Analyst Color

Price Target

Initiation

Analyst Ratings

General

Viking Holdings' Premium Valuation Warrants A More Favorable Entry Point: Analyst

Freeport-McMoRan Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>), a global leader in producing copper, gold and molybdenum, approaches its fourth-quarter earnings report, set for release in Thursday's pre-market session, bolstered by a strong third-quarter performance that <a href="https://www.benzinga.com/news/earnings/24/10/41453243/freeport-mcmoran-beats-q3-estimates-gold-sales-soar-copper-production-stabilizes">surpassed market expectations</a>.
According to <a href="https://www.benzinga.com/quote/FCX/earnings">analyst consensus estimates</a>, Freeport-McMoRan is expected to report fourth-quarter EPS of 21 cents on revenue of $5.93 billion.
What To Know: Freeport-McMoRan in the third quarter reported revenue of $6.79 billion, beating the consensus of $6.47 billion, with adjusted EPS of $0.38 surpassing estimates of $0.35. 
Despite facing challenges such as lower ore grades and operating rates in North America, copper sales totaled 1 billion pounds, driven by favorable shipment timing.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43139850/intel-vs-amd-server-battle-ai-race-frame-earnings-test">Intel Vs. AMD: Server Battle, AI Race Frame Earnings Test</a>
Additionally, gold sales were a standout, rising 40% year-over-year to 558 thousand ounces, while average realized prices for copper and gold stood at $4.30 per pound and $2,568 per ounce, respectively.
What Else: For the fourth quarter, Freeport-McMoRan said the company expects to deliver consolidated sales volumes of 1 billion pounds of copper, 450 thousand ounces of gold, and 20 million pounds of molybdenum. With a full-year operating cash flow forecast of $6.8 billion, assuming stable pricing, the company is well-positioned to sustain robust cash generation. 
During third quarter commentary FCX added the company continues to focus on productivity improvements, cost control and recovery efforts at its Indonesia smelter, which was recently affected by fire damage. 
Read Also: <a href="https://www.benzinga.com/general/entertainment/25/01/43136402/netflix-stock-firing-on-all-cylinders-10-analysts-react-to-q4-beat-guidance-price-increases">Netflix Stock &#8216;Firing On All Cylinders&#8217;: 10 Analysts React To Q4 Beat, Guidance, Price Increases</a>
Investors can gain exposure to FCX by investing in the iShares Copper and Metals Mining ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICOP#NASDAQ">ICOP</a>).
<h2 class="wp-block-heading">How To Buy FCX Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Freeport-McMoRan&#8217;s case, it is in the Materials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, FCX has a 52-week high of $55.24 and a 52-week low of $36.26.

ICOP

What's Going On With Freeport-McMoRan (FCX) Stock Ahead Of Q4 Earnings Report?

Technology giant NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) enters 2025 celebrating several milestones including record financial results, becoming the most valuable company and a member of the <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/11/41724410/nvidia-joining-dow-jones-industrial-average-where-tech-giant-ranks-in-the-index-why-sh">Dow Jones Industrial Average</a>.
The company celebrates its IPO anniversary on Jan. 22. Here's a look back at how much the lucky and perhaps wise investors who bought shares of Nvidia at IPO would have made.
Investing $1,000 in Nvidia at IPO: Nvidia became one of the <a href="https://www.benzinga.com/news/23/05/32630114/nvidia-becomes-ninth-company-to-hit-1-trillion-market-cap-who-could-be-next-to-join-elusive-club">most valuable companies</a> in the world in May 2023, passing the $1 trillion market capitalization level.
Since that time, the company went on to pass the $2 trillion and $3 trillion market capitalization levels. At the time of writing, Nvidia is the <a href="https://www.benzinga.com/news/large-cap/24/11/41761849/nvidia-blows-past-apple-to-become-worlds-most-valuable-company">most valuable company</a> in the world valued at $3.589 trillion, slightly ahead of Apple ($3.339 trillion).
Back in 1999, Nvidia held its initial price offering on Jan. 22, with shares priced at $12 each.
A $1,000 investment in the company would have been able to buy 83.33 shares at the time.
Since its IPO, Nvidia had several stock splits that increased the number of shares held by shareholders. The stock had 2:1 splits in 2000, 2001 and 2006, a 3:2 split in 2007, a 4:1 split in July 2021 and the most recent 10:1 split in June 2024.
Today, the original 83.33 shares would total 39,998.4 shares after the stock splits.
The original $1,000 investment in Nvidia stock would be worth $5,862,965.47 based on a share price of $146.58. This represents a huge return for Nvidia IPO buyers with some potential millionaires created over the years.
Here's a look at the return of Nvidia since its IPO with a&nbsp;<a href="http://•	https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012225&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro Chart</a>&nbsp;below.
<figure class="wp-block-image size-full"><a href="•	https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012225&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="503" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22124524/Screenshot-305.png" alt="" class="wp-image-745246" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22124524/Screenshot-305.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22124524/Screenshot-305-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22124524/Screenshot-305-768x387.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
For comparison, the same $1,000 invested in the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSPY#NYSE">VSPY</a>), which tracks the S&amp;P 500, would have underperformed Nvidia.
A $1,000 investment in SPY stock could have bought 12.82 shares at the time, based on an adjusted price of $78.03 on Jan. 22, 1999.
The $1,000 invested in the SPDR S&amp;P 500 ETF Trust would be worth $7,789.94 today.
Are you buying when the CEOs of the Magnificent 7 are selling?
<ul>
<li>Stay in the know with our Insider Trades page — <a href="https://www.benzinga.com/sec/insider-trades/">see when leaders like Mark Zuckerberg, Elon Musk, and Jensen Huang are offloading their own shares.</a></li>
</ul>
What Happened:&nbsp;Nvidia has been at the forefront of the AI revolution and growth as a leader in the sector, which helped boost the stock price over the last several years.
Since its was <a href="https://www.nvidia.com/en-us/about-nvidia/corporate-timeline/" target="_blank" rel="noreferrer noopener">founded </a>in 1993, Nvidia has sought to be at the forefront of technological advancements to help new industrial advancements.
In 1999, the company invented the Graphics Processing Unit, commonly known as GPU today. The GPU redefined the computer industry.
In 2012, Nvidia ushered in the modern era of AI with the AlexNet neural network, potentially showing the company ahead of others when it came to belief in the capabilities of artificial intelligence.
In March 2024. the company&nbsp;<a href="https://www.benzinga.com/news/24/03/37809836/nvidia-reveals-blackwell-gpu-highlights-partnerships-with-top-companies-at-gtc-the-whole-industry-is" target="_blank" rel="noreferrer noopener">unveiled the&nbsp;Blackwell GPU</a>,&nbsp;which could help the company further disrupt the growth of artificial intelligence.
What's Next: Nvidia continues to <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42119226/nvidia-analysts-see-stock-best-positioned-in-ai-not-worried-about-guidance-all-systems-go-for-blackwell-ramp">draw praise from analysts</a> as one of the best plays on the growth of artificial intelligence.
The big question for investors today is if Nvidia will keep outperforming the overall market and be one of the top-performing stocks going forward.
Nvidia <a href="https://www.benzinga.com/news/earnings/24/11/42099904/nvidia-beats-q3-revenue-eps-estimates-supply-constraints-ding-stock-huang-says-age-of-ai-is-in-full-steam">beat analyst estimates</a> in the third quarter for both revenue and earnings per share. Nvidia CEO Jensen Huang highlighted the continued growth of AI and the company's new products seeing huge demand.
"The age of AI is in full steam, propelling a global shift to NVIDIA computing," Huang said at the time.
Huang said countries have "awakened to the importance" of AI.
"AI is transforming every industry, company and country. Enterprises are adopting agentic AI to revolutionize workflows. Industrial robotics investments are surging with breakthroughs in physical AI."
President Donald Trump has put an <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43128141/tech-stocks-rise-after-trump-announces-ai-infrastructure-investment">early emphasis on artificial intelligence,</a> which could help boost the Nvidia share price over time. In 2017, Nvidia was the <a href="https://www.benzinga.com/general/politics/24/10/41584466/these-10-stocks-were-the-best-s-p-500-performers-in-2017-when-trump-was-president-will-history-r">ninth best performing</a> S&amp;P 500 stock during Trump's first year in the White House. Investors will be hoping Trump back in office is good for Nvidia and AI.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/management/24/10/41294313/does-jensen-huang-check-nvidia-stock-price-daily">Does Jensen Huang Check Nvidia Stock Price Daily?</a></li>
</ul>
This article was previously published by Benzinga and has been updated.
Photo: Shutterstock

Education

Tech

NVDA

VSPY

If You Invested $1,000 In Nvidia Stock At IPO, Here's How Much You'd Have Today

Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) is down 6% after the <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43095721/dogecoin-up-2-after-logo-appears-on-doge-department-site">Department of Government Efficiency</a> website removed the iconic Shiba Inu imagery, a symbol closely tied to the meme coin&#8217;s popularity.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td> $0.358</td>
<td> -6.4%</td>
<td> -4.4%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td> $0.00002025</td>
<td> -3.9%</td>
<td> -8.6%</td>
</tr>
<tr>
<td>Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td> $0.00001534</td>
<td> -4.5%</td>
<td> -16.8%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Despite the dip, crypto chart analyst Ali Martinez remains bullish, forecasting a breakout to $0.39.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> <a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> appears to form a falling wedge, anticipating a breakout to $0.39! <a href="https://t.co/EDZaRoBFE4">pic.twitter.com/EDZaRoBFE4</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1882070143129539013?ref_src=twsrc%5Etfw">January 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Altcoin Sherpa is also cautiously optimistic, <a href="https://x.com/AltcoinSherpa/status/1882044628070957514">considering</a> a long position in DOGE. 
He notes that if Bitcoin rallies, Dogecoin is likely to ride the momentum.
Meanwhile, More Crypto Online highlights that while DOGE's current price structure appears weak, it could still align with a larger bullish wave formation. H
owever, a drop below Jan 21&#8217;s low might indicate alternative bearish scenarios.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a>: I prefer that the price holds above this week's low, but the structure looks pretty lousy. The assumption is that the price has formed a larger wave 4 low in December, and is now working on a larger diagonal pattern in circle wave 2. A break below yesterday's low opens the… <a href="https://t.co/Y0rkbuZ0WX">pic.twitter.com/Y0rkbuZ0WX</a>
&mdash; More Crypto Online (@Morecryptoonl) <a href="https://twitter.com/Morecryptoonl/status/1882081335457579296?ref_src=twsrc%5Etfw">January 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Community News: The Department of Government Efficiency's <a href="https://doge.gov/">website</a> no longer features the Shiba Inu imagery, which had become a symbol of Dogecoin and the broader meme coin movement. 
The agency, co-led by Elon Musk, focuses on streamlining government operations by cutting budgets and reducing jobs.
The agency also saw leadership changes recently, with <a href="https://www.benzinga.com/news/25/01/43078027/vivek-ramaswamy-expected-to-exit-trumps-doge-task-force-amid-ohio-governor-bid-report">Vivek Ramaswamy stepping away</a> to focus on his Ohio governor campaign.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43123419/dogecoin-down-7-shiba-inu-declines-3-whats-going-on">Dogecoin Down 7%, Shiba Inu Declines 3%: What&#8217;s Going On?</a></li>
</ul>
Image: Shutterstock

$DOGE

$PEPE

$SHIB

Dogecoin Drops 6% After DOGE Department Removes Logo

RDDT

Reddit shares are trading lower after Roth MKM downgraded the stock from Buy to Neutral.

GMAB

Genmab shares are trading lower. The company reported FY24 net sales for Darzalex.

<a href="https://www.statnews.com/2025/01/22/trump-hhs-secretary-pick-rfk-jr-financial-disclosures-biotech-investments-book-advances/">https://www.statnews.com/2025/01/22/trump-hhs-secretary-pick-rfk-jr-financial-disclosures-biotech-investments-book-advances/</a>
&nbsp;
President Trump's nominee to lead the health department, Robert F. Kennedy Jr., invested in gene-editing technology and is owed substantial advances for several books, according to financial disclosures released ahead of his confirmation hearings.&nbsp;
The disclosures give the clearest view to date of RFK Jr.'s investments, employment, and potential conflicts of interest. They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He's also stepping down from roles at his law firm and at the anti-vaccine nonprofit Children's Health Defense.
Trump tapped RFK Jr. to lead the Department of Health and Human Services after Kennedy ended his presidential campaign and endorsed Trump. Confirmation hearings haven't yet been scheduled.
 &nbsp;

Politics

CRSP

Watching CRISPR Therapeutics; Shares See Volume To The Upside, Traders Circulate STAT News Article Titled "RFK Jr. invested in gene-editing biotech, is owed millions for book advances, disclosures show"

Woodside Energy Group shares are trading lower. The company reported Q4 financial results and provided FY25 guidance.

Donald Trump's inauguration and the <a href="https://www.benzinga.com/25/01/43088840/donald-and-melania-trump-memecoins-crash-after-presidential-inaugurationfirst-couples-crypto-wealth-plunges-36">preceding meme coin launch</a> have sent ripples through the crypto ecosystem, with his administration&#8217;s early signals sparking both optimism and scepticism within the industry.
What Happened: The latest episode of the Unchained podcast discussed this unexpected <a href="https://www.benzinga.com/25/01/43079586/donald-melania-launch-official-memecoins-heres-how-much-the-husband-wife-duo-possibly-made-with-their-latest-crypto-forays">launch</a> of TRUMP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TRUMP</a>) on Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>).
Ram Ahluwalia, who attended Washington D.C.'s &#8220;Crypto Ball,&#8221; <a href="https://www.youtube.com/watch?v=CM_Y1xuXOes">described</a> the coin's debut as "extremely well executed," reaching a market cap of several billion dollars. 
However, detractors have labeled the coin a &#8220;grift,&#8221; raising ethical concerns about intertwining politics with speculative financial products.
James Seyffart of Bloomberg noted, "While the Trump coin was a successful launch, it underscores the high-risk nature of such investments. For most traders, this is like gambling."
Adding to the frenzy, a counterfeit &#8220;Barron Trump&#8221; coin briefly reached a $400 million market cap before collapsing, fueling further skepticism about the sustainability of meme coin hype.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43136512/bitcoin-is-no-threat-to-the-us-dollar-goldman-sachs-ceo-says">Bitcoin Is No &#8216;Threat&#8217; To The US Dollar, Goldman Sachs CEO Says</a>
Beyond the meme coin mania, the crypto sector is eagerly watching for executive orders that could shape the future of digital assets under the Trump administration.
Although speculation has mounted around the <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43135463/strategic-bitcoin-reserve-probability-up-to-64-despite-trump-silence-on-crypto">establishment of a &#8220;strategic Bitcoin reserve,&#8221;</a> Trump&#8217;s <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43085738/trumps-crypto-silence-inauguration-omission-sparks-questions-after-history-of-mixed-signals">inauguration speech made no mention of cryptocurrency</a>, prompting Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) to drop 5% in value. 
Seyffart suggested a possible executive order to retain government-held Bitcoin as a starting point for crypto policies.
Additional crypto-related executive orders discussed on the podcast included halting the ongoing &#8220;crypto crackdown&#8221; and promoting domestic Bitcoin mining.
What's Next: Trump's broader economic strategies could have far-reaching implications for crypto markets. 
Ahluwalia noted that policies prioritizing economic growth and innovation might boost investor sentiment and market momentum.
However, the <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42995279/federal-reserve-policy-reversal-buzz-around-2025-rate-hikes-gains-momentum-its-a-paper-barrier-will-break-through-it-quickly-if-the-data-becomes-overwhelming">Federal Reserve&#8217;s next moves remain uncertain</a>. 
While some experts argue rate cuts may no longer be needed, others believe economic shifts under Trump's policies could prompt the Fed to adjust its stance later in the year.
With the crypto industry bracing for potential executive orders, the coming weeks will likely reveal how the Trump administration plans to engage with digital assets and regulation.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43126318/bitcoin-is-a-meme-coin-says-peter-schiff-critics-clap-back-goldbugs-are-no-different-from-bitcoin-maxis">&#8216;Bitcoin Is A Meme Coin&#8217; Says Peter Schiff, Critics Clap Back: &#8216;Goldbugs Are No Different From Bitcoin Maxis&#8217;</a></li>
</ul>
Image created using artificial intelligence with Midjourney.

$SOL

$TRUMP

What Comes Next After Donald Trump's Meme Coin Launch?

MRNA

Moderna shares are trading higher after Oracle Chairman Larry Ellison discussed AI in cancer vaccines.

NRG Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) today announced that its Board of Directors declared a quarterly dividend on the Company's common stock of $0.44 per share, or $1.76 per share on an annualized basis. This dividend represents an 8% increase from the prior year, in line with the Company's previously announced annual dividend growth rate target of 7-9% per share. The dividend is payable on February 18, 2025, to stockholders of record as of February 3, 2025.

Dividends

NRG Energy Increases Quarterly Dividend From $0.41 To $0.44 Per Share

Eversource Energy shares are trading lower after Barclays cut its price target on the stock from $72 to $69.

Clean Harbors's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLH#NYSE">CLH</a>) short percent of float has fallen 8.55% since its last report. The company recently reported that it has 540 thousand shares sold short, which is 1.07% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.71 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Clean Harbors Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737573323_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Clean Harbors has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Clean Harbors's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Clean Harbors's peer group average for short interest as a percentage of float is 3.49%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(CLH) - Analyzing Clean Harbors's Short Interest

Inmed Pharmaceuticals Inc. ( ($INM) ) has released its Q1 earnings. Here is a breakdown of the information Inmed Pharmaceuticals Inc. presented to ...

InMed Pharmaceuticals Reports Improved Quarterly Earnings

InMed Pharmaceuticals (INM) has released an update. InMed Pharmaceuticals has published a promising study showcasing the anti-inflammatory effects ...

InMed's Study Highlights Cannabinol's Potential in Skincare

InMed Pharmaceuticals ( ($INM) ) has issued an update. InMed Pharmaceuticals has published a study revealing the potential of cannabinol (CBN) as a...

InMed Pharmaceuticals Explores CBN for Skin Disease Treatment

InMed Pharmaceuticals (INM) has released an update. InMed Pharmaceuticals has entered into a Standby Equity Purchase Agreement with Yorkville Advis...

InMed Pharmaceuticals Secures $10 Million Equity Purchase Agreement

InMed Pharmaceuticals (INM) has released an update. InMed Pharmaceuticals announced the results of their 2024 Annual General Meeting, where shareho...

InMed Pharmaceuticals' 2024 AGM Results Announced

17:21 EST InMed Pharmaceuticals (INM) files to sell 3M common shares for holders Published first on TheFly – the ultimate source for real-time, mar...

InMed Pharmaceuticals files to sell 3M common shares for holders

InMed Pharmaceuticals ( ($INM) ) has provided an update. InMed Pharmaceuticals announced positive results from a long-term preclinical study of its...

InMed's INM-901 Shows Promising Results in Preclinical Alzheimer's Study

InMed Pharmaceuticals (INM) announces "positive" results from a long-term in vivo preclinical Alzheimer's Disease study. In the study, INM-901 demo...

InMed announces 'positive' results from in vivo preclinical Alzheimer's study

InMed Pharmaceuticals (INM) announces it has been granted an international Patent Cooperation Treaty, PCT, patent in the first of several jurisdict...

InMed Pharmaceuticals granted an international PCT patent

An update from InMed Pharmaceuticals ( ($INM) ) is now available. InMed Pharmaceuticals has announced the granting of an international Patent Coope...

InMed Pharmaceuticals Secures Key Patent for Cannabinoid Analogs

Screenshot 2024-08-27 at 5.44.40 PM

Biotech

InMed Demonstrates Encouraging Data For Its Cannabinoid INM-089 In Treating Dry AMD, An Ocular Disease With Rising Patient Numbers As National Population Ages

Comments

InMed Pharmaceuticals

InMed Pharmaceuticals (INM) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル